- About Us
- Technology Platform
- Zosano Pharma Announces Pricing of Initial Public Offering
- PRESS RELEASE
- Zosano Pharma Appoints Troy Wilson, Ph.D., J.D., to Board of Directors
- Zosano Pharma Files Registration Statement for Proposed Initial Public Offering
- Zosano Pharma, Inc. to Present at the 74th American Diabetes Association (ADA) Scientific Session
- Zosano Pharma Appoints Winnie W. Tso, CPA as Chief Financial Officer
- Zosano Pharma, Inc. to Present at the 3rd International Microneedle Conference
- Zosano Pharma Enters into a License Agreement with Novo Nordisk
- Zosano Pharma, Inc. Appoints Nandan Oza as Chief Operations Officer
- Zosano Pharma, Inc. Expands Board of Directors with Addition of Kleanthis G. Xanthopoulos, Ph.D.
- Zosano Pharma, Inc. Announces Key Strategic Hire
- Zosano Pharma, Inc. and Asahi Kasei Pharma Corporation Enter Exclusive Licensing Agreement
- Zosano Pharma, Inc. To Present At The 14Th Annual Drug Delivery Partnerships Meeting..
- Zosano Pharma, Inc. Announces Publication of Positive Phase 2 Study of its ZP-PTH Patch for Osteo..
- Zosano Pharma, Inc. Secures $30 Million In New Round Of Financing
- Zosano Pharma, Inc. Completes Positive End-Of-Phase 2 Meeting With Fda Regarding ZP- PTH Patch...